ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona
HU
Hospital Universitario 12 de Octubre at ESMO 2026
Oct 23–27, 2026 Madrid, Spain ~37k attendees Website
Hospital Universitario 12 de Octubre takes part in 26 sessions at ESMO 2026 in Madrid, its home city. Its program spans several cancers, including breast, lung and gynaecological cancers, alongside precision oncology. Specific topics include treatment choices for advanced breast cancer and monitoring bladder cancer without invasive procedures.
| Organization | ESMO 2026 Attendance |
|---|---|
HU Hospital Universitario 12 de Octubre Madrid, Spain | |
Public university hospital of the Madrid regional health service, affiliated with Complutense University, in Madrid, Spain. | Poster Fri Oct 23 13:00–15:00 Diagnostic and treatment pathway experience in primary brain tumours: A cross-sectional analysis Sarcoma, CNS, head & neck and rare cancers Poster Fri Oct 23 13:00–15:00 Independent validation of TNBCDX in early-stage triple-negative breast cancer in a real-world cohort Breast cancerBiomarkers & precision oncology Chair Fri Oct 23 13:30–15:00 SCLC: Can we finally tackle it? Lung & thoracic cancers Poster Fri Oct 23 15:15–16:00 Baseline and On-Treatment Urinary Tumor DNA Molecular Residual Disease (utDNA MRD) and Clinical Response to Gemcitabine Intravesical System (Gem-iDRS) in SunRISe-1 (SR-1): Updated Analysis Genitourinary cancersBiomarkers & precision oncology Poster Fri Oct 23 15:15–16:00 Poster Fri Oct 23 15:15–16:00 Satellite Fri Oct 23 18:15–19:45 Menarini Stemline - ESR1-mutated Advanced Breast Cancer: A Transforming Treatment Landscape Breast cancerBiomarkers & precision oncology Satellite Fri Oct 23 18:15–18:20 Welcome and Introductions Breast cancerBiomarkers & precision oncology Satellite Fri Oct 23 18:20–18:45 Post-CDK4/6i Progression in ER+/HER2– mBC: The EU Landscape in 2026 Breast cancerBiomarkers & precision oncology Satellite Fri Oct 23 18:35–18:50 Interpreting evidence for durable survival in dMMR/MSI-H EC Gynaecological cancers Satellite Fri Oct 23 19:00–19:40 Satellite Fri Oct 23 19:15–19:40 Mapping change: Evolving clinical practice and conversations Gynaecological cancers Satellite Fri Oct 23 19:35–19:45 Summary and Closing Breast cancerBiomarkers & precision oncology Chair Sat Oct 24 14:45–15:45 YO Lecture: What to expect from precision medicine in the next decade Biomarkers & precision oncology Talk Sat Oct 24 15:30–15:45 Neuroendocrine tumors (NET) Sarcoma, CNS, head & neck and rare cancers Satellite Sat Oct 24 18:35–18:55 HER2-mutant NSCLC: Transforming precision medicine into clinical reality Lung & thoracic cancers Satellite Sat Oct 24 19:25–19:45 Establishing the present of clinical practice Lung & thoracic cancers Chair Sun Oct 25 08:30–10:00 Rapid oral 2: NSCLC, metastatic Lung & thoracic cancers Abstract Sun Oct 25 08:40–08:52 Invited Discussant LBA76 and 2616RO Lung & thoracic cancers Talk Sun Oct 25 09:10–09:50 Abstract Sun Oct 25 10:20–10:25 Poster Sun Oct 25 12:00–12:45 Non-invasive monitoring for severe neutropenia: Optimal timing for preventing febrile neutropenia and its clinical impact (PC001-005 study group) Haematological malignanciesNursing & supportive care Poster Sun Oct 25 12:00–12:45 Poster Sun Oct 25 12:00–12:45 Chair Sun Oct 25 14:45–16:15 Chair Sun Oct 25 15:00–16:00 Talk Sun Oct 25 15:35–16:00 Satellite Sun Oct 25 19:00–19:10 Digital pathology and AI: How do we implement them and show clinical impact? Biomarkers & precision oncology Talk Mon Oct 26 08:30–08:50 Poster Mon Oct 26 12:00–12:45 CTNNB1 mutations in non-small cell lung cancer (NSCLC): Clinical outcomes and response to targeted therapy in a multicenter real-world cohort Lung & thoracic cancersBiomarkers & precision oncology Poster Mon Oct 26 12:00–12:45 Poster Mon Oct 26 12:00–12:45 FIT-NETs: Effects of an exercise program on physical and emotional well-being in patients with advanced digestive or unknown primary G1-2 neuroendocrine tumors (NETs) Sarcoma, CNS, head & neck and rare cancersNursing & supportive care Poster Mon Oct 26 12:00–12:45 Systemic therapy in advanced gastric neuroendocrine neoplasms (G-NENs): Real-world evidence from the R-GETNE National Registry (G-NENCARE) Sarcoma, CNS, head & neck and rare cancers Satellite Mon Oct 26 13:00–14:30 Daiichi Sankyo and MSD - Shaping the Future of ES-SCLC: Pioneering Treatment Strategies Lung & thoracic cancers Satellite Mon Oct 26 13:00–13:05 Welcome and Introduction Lung & thoracic cancers Satellite Mon Oct 26 13:55–14:15 Improving Patient Outcomes: Lessons from Other Indications Lung & thoracic cancers |
Find decision makers at Hospital Universitario 12 de Octubre
Tell us what you sell and we’ll find the people at Hospital Universitario 12 de Octubre most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction